IFNGR1 and precursor B-cell acute lymphoblastic leukemia: Taken together, these data suggest that intratumoral IFNγR/JAK/STAT signaling, along with downstream antigen processing and presentation pathways, may be key determinants of CAR-T response in human B-ALL (Fig. 6d).